ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,293 | +2.4% | 72,018 | +15.8% | 0.06% | +10.9% |
| Q2 2023 | $1,263 | -40.3% | 62,188 | -46.4% | 0.06% | -45.0% |
| Q1 2023 | $2,117 | +664.3% | 116,089 | +767.4% | 0.10% | +566.7% |
| Q4 2022 | $277 | -100.0% | 13,383 | -63.1% | 0.02% | -73.7% |
| Q3 2022 | $949,000 | +65.0% | 36,293 | +60.0% | 0.06% | +32.6% |
| Q2 2022 | $575,000 | +63.4% | 22,690 | -10.6% | 0.04% | -70.9% |
| Q1 2020 | $352,000 | -65.8% | 25,378 | -75.1% | 0.15% | -51.8% |
| Q4 2019 | $1,029,000 | +619.6% | 101,846 | +549.9% | 0.31% | +479.2% |
| Q3 2019 | $143,000 | – | 15,670 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |